🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11298+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11298 recruiting trials

NAEnrolling by InvitationNCT05902026

The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache

👨‍⚕️ Aysenur TUNCER, PhD, Hasan Kalyoncu University📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06522386

GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma

👨‍⚕️ Michael Wang, MD, MS, M.D. Anderson Cancer Center📍 2 sites📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06564038

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

🏥 AstraZeneca📍 63 sites📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06616636

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

👨‍⚕️ Courtney DiNardo, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06692400

The Effects of Endotracheal Suctioning on Pain and Serum Markers

👨‍⚕️ Elizabeth Johnston Taylor, PhD, FAAN, Loma Linda University School of Nursing📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT06710132

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

👨‍⚕️ Medical Responsible, Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany📍 81 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06790082

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

👨‍⚕️ Helle Zacho, MD, DMSc, Clinical Professor dept. of Nuclear Medicine, Aalborg University Hospital📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06877936

Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)

🏥 Ramsay Générale de Santé📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06597734

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

👨‍⚕️ Kelly Chien, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06722352

Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

👨‍⚕️ Debra Dobbs, PhD, University of South Florida📍 2 sites📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06485947

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

👨‍⚕️ Holger Lode, MD, PhD, Princess Maxima Center for Pediatric Oncology📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06498973

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

👨‍⚕️ Hoda Z Pourhassan, MD, City of Hope Medical Center📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06805474

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

👨‍⚕️ Samuel Barone, MD, Nanoscope Therapeutics Inc.📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT06717347

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 248 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06804122

Exercise-based Rehabilitation in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Jussi A Hernesniemi, MD PhD, Tampere Heart Hospital📍 1 site📅 Started Jan 2025View details ↗
NAEnrolling by InvitationNCT06798493

CSS-SR Validation Study

👨‍⚕️ Alexandra Sideris, PhD, Hospital for Special Surgery, New York📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT05140525

Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke Health System📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06747923

SB17170 Phase 2 Trial in IPF Patients

🏥 SPARK Biopharma📍 5 sites📅 Started Jan 2025View details ↗
NARecruitingNCT06789705

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

👨‍⚕️ Mirjam Christ-Crain, Prof., University Hospital, Basel, Switzerland📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06174428

Validity of Viome's Oral/throat Cancer Test

👨‍⚕️ Cristina Julian, Viome📍 2 sites📅 Started Jan 2025View details ↗
← PreviousPage 171 of 565Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →